M. Manfredi, S. Martinotti, M. Patrone, M. Sassi, E. Ranzato, E. Marengo
{"title":"无标记质谱技术靶向定量HMGB1蛋白","authors":"M. Manfredi, S. Martinotti, M. Patrone, M. Sassi, E. Ranzato, E. Marengo","doi":"10.1109/MeMeA.2015.7145260","DOIUrl":null,"url":null,"abstract":"Mass spectrometry (MS)-based methods have become popular in recent years for the quantitation of biomolecules, especially peptides and proteins. High Mobility Group Box-1 protein (HMGB1) is a nuclear DNA-binding protein that resides inside the nucleus and can be released to the extracellular space under specific conditions. HMGB1 has been reported as circulating mechanistic indicators of cell death mode in animal models and in clinical studies. There is accumulating evidence that HMGB1 contributes to the pathogenesis of inflammatory and autoimmune diseases. Moreover, HMGB1 has been found to play an important role in tumor development, growth, and spread. Circulating HMGB1 level could be a useful and specific marker for evaluating different disease status and predicting prognosis in patients. The label-free quantitative comparison without any standard reference or normalization of the target peptide signal is the simplest Liquid Chromatographic-MS (LC-MS) method for the quantitation of a protein. The aim of the research was the development of an analytical method for the quantitation of HMGB1 by a label-free Mass Spectrometry technique. In this paper are presented the preliminary results: the quantitation of HMGB1 was assessed in a cell lysate sample through the use of the standard concentration curve of purified HMGB1 protein.","PeriodicalId":277757,"journal":{"name":"2015 IEEE International Symposium on Medical Measurements and Applications (MeMeA) Proceedings","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Targeted quantitation of HMGB1 protein by label-free Mass Spectrometry technique\",\"authors\":\"M. Manfredi, S. Martinotti, M. Patrone, M. Sassi, E. Ranzato, E. Marengo\",\"doi\":\"10.1109/MeMeA.2015.7145260\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Mass spectrometry (MS)-based methods have become popular in recent years for the quantitation of biomolecules, especially peptides and proteins. High Mobility Group Box-1 protein (HMGB1) is a nuclear DNA-binding protein that resides inside the nucleus and can be released to the extracellular space under specific conditions. HMGB1 has been reported as circulating mechanistic indicators of cell death mode in animal models and in clinical studies. There is accumulating evidence that HMGB1 contributes to the pathogenesis of inflammatory and autoimmune diseases. Moreover, HMGB1 has been found to play an important role in tumor development, growth, and spread. Circulating HMGB1 level could be a useful and specific marker for evaluating different disease status and predicting prognosis in patients. The label-free quantitative comparison without any standard reference or normalization of the target peptide signal is the simplest Liquid Chromatographic-MS (LC-MS) method for the quantitation of a protein. The aim of the research was the development of an analytical method for the quantitation of HMGB1 by a label-free Mass Spectrometry technique. In this paper are presented the preliminary results: the quantitation of HMGB1 was assessed in a cell lysate sample through the use of the standard concentration curve of purified HMGB1 protein.\",\"PeriodicalId\":277757,\"journal\":{\"name\":\"2015 IEEE International Symposium on Medical Measurements and Applications (MeMeA) Proceedings\",\"volume\":\"24 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-05-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2015 IEEE International Symposium on Medical Measurements and Applications (MeMeA) Proceedings\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/MeMeA.2015.7145260\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2015 IEEE International Symposium on Medical Measurements and Applications (MeMeA) Proceedings","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/MeMeA.2015.7145260","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
近年来,基于质谱(MS)的方法在生物分子,特别是多肽和蛋白质的定量分析中越来越受欢迎。High Mobility Group Box-1 protein (HMGB1)是一种核dna结合蛋白,存在于细胞核内,在特定条件下可被释放到细胞外空间。HMGB1已在动物模型和临床研究中被报道为细胞死亡模式的循环机制指标。越来越多的证据表明HMGB1参与炎症和自身免疫性疾病的发病机制。此外,HMGB1已被发现在肿瘤的发生、生长和扩散中发挥重要作用。循环HMGB1水平可作为评价不同疾病状态和预测患者预后的一个有用的特异性指标。无标记定量比较,不需要任何标准参比或目标肽信号的归一化,是最简单的定量蛋白质的液相色谱-质谱(LC-MS)方法。本研究的目的是开发一种无标记质谱技术用于HMGB1定量的分析方法。本文给出了初步结果:通过使用纯化后的HMGB1蛋白的标准浓度曲线,在细胞裂解液样品中评估了HMGB1的定量。
Targeted quantitation of HMGB1 protein by label-free Mass Spectrometry technique
Mass spectrometry (MS)-based methods have become popular in recent years for the quantitation of biomolecules, especially peptides and proteins. High Mobility Group Box-1 protein (HMGB1) is a nuclear DNA-binding protein that resides inside the nucleus and can be released to the extracellular space under specific conditions. HMGB1 has been reported as circulating mechanistic indicators of cell death mode in animal models and in clinical studies. There is accumulating evidence that HMGB1 contributes to the pathogenesis of inflammatory and autoimmune diseases. Moreover, HMGB1 has been found to play an important role in tumor development, growth, and spread. Circulating HMGB1 level could be a useful and specific marker for evaluating different disease status and predicting prognosis in patients. The label-free quantitative comparison without any standard reference or normalization of the target peptide signal is the simplest Liquid Chromatographic-MS (LC-MS) method for the quantitation of a protein. The aim of the research was the development of an analytical method for the quantitation of HMGB1 by a label-free Mass Spectrometry technique. In this paper are presented the preliminary results: the quantitation of HMGB1 was assessed in a cell lysate sample through the use of the standard concentration curve of purified HMGB1 protein.